MilliporeSigma’s New Microbial Bioburden Testing System Offers Enhanced Results and Increased Productivity

News
Article

Pharmaceutical Technology's In the Lab eNewsletter

In the Lab eNewsletterPharmaceutical Technology\'s In the Lab eNewsletter-02-05-2020
Volume 15
Issue 2

The company’s new Milliflex Oasis System provides enhanced result reliability, increased productivity, and advanced traceability.

MilliporeSigma’s latest innovation, the Milliflex Oasis System, offers enhanced benefits for pharmaceutical bioburden and water testing. It has 96 new features to increase result reliability and traceability while streamlining the bioburden testing workflow, the company reports.

The benefits of the new system include:

  • Operator-independent handling steps, improved touch-free membrane transfer with color-coded components for increased result reliability

  • 50% faster filtration time compared with previous product generation

  • Scalable hardware for high throughput

  • Reduced decontamination and maintenance time for optimized productivity

  • 2-dimensional codes and labels on primary and secondary packaging, on each funnel and media plate, for traceability and regulation compliance

The system also offers an all-in-one filtration solution with sterilized, ready-to-use filtration units and pharmacopeia-compliant media for comfort and peace of mind for water and bioburden testing, according to the company. MilliporeSigma launched the Milliflex Oasis System on Jan. 29, 2020.

Source: MilliporeSigma

Recent Videos
Drug Digest: Strategic Partnerships
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Henny Zijlstra from Adragos Pharma chats about the trends affecting the outsourcing market, various strategies being employed by service providers, and the value of end-to-end services.